KrystoLens from Brain Navi Receives TFDA Certification, Set to Enter Taiwan Market

---
KrystoLens from Brain Navi Receives TFDA Certification, Set to Enter Taiwan Market
Vote:
0 0
Previous Eason Technology Completes First $1Million Investments in Energy Fund and Facilitate Business Expansion Into The Energy Sector
Next MoEngage Launches Merlin AI Custom Agents With Full Visibility, Marketer-Defined Guardrails, and Open MCP Architecture

Related News

Brain Navi Begins IPO Counseling with First Securities Inc., Setting the Stage for Global MedTech Expansion

Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac

BenQ Medical Technology and Brain Navi Align Partnership to Advance Neurosurgical Robotics in China

Primo's Taoyuan Facility Achieves PIC/S GMP Certification, Paving the Way for Global Expansion in Nuclear Medicine.

Bolivian and Taiwanese Experts Discuss the Latest Med-Tech Developments to Position Bolivia as a Leading hub in Robotic Neurosurgery

NX Taiwan Becomes First Japanese Company to Receive QMS Certification for Medical Devices at Its NEXT3 Warehouse in Taoyuan City

menu
menu